iTonic Holdings Ltd Class A

Stage 4 · Declining · week 15

As of Oct 22, 2026, iTonic Holdings is in Stage 4, the downtrend phase, now in week 15 (since Jul 15, 2026). It closed at $3.23, 77.6% below its 52-week high and below its 200-day average, which is falling.

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. More about the company

$3.23

-8.76% today

$23.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ITOC early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-09-05 → 2026-10-22

S? 42w

S4 38w

S4 14w

2024-09-052026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S2 8w → S3 4w → S4 38w → S1 4w → S4 14w current

Total tracked: 111 weeks across 6 stage runs.

ITOC among Medical Devices100th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…100	ITOCiTonic Holdings Ltd Class A	Stage 4 · wk 15	16	−37.5%

vs 52W High

-77.6%

$3.23 lo$14.43 hi

77.6% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 15

1w13w26w

Week 15, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-39.5%

200 DMA: $5.34 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.14x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-37.5%

-23.8%

-32.7%

YTD

-53.5%

-68.0%

Scan Membership

Breakout Watch

Latest: 2025-06-24

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 15 · Vol 0.14x

2026-10-21S4

Wk 14 · Vol 0.03x

2026-10-20S4

Wk 14 · Vol 0.11x

2026-10-19S4

Wk 14 · Vol 0.18x

2026-10-16S4

Wk 14 · Vol 0.22x

2026-10-15S4

Wk 14 · Vol 0.17x

2026-10-14S4

Wk 13 · Vol 0.60x

2026-10-13S4

Wk 13 · Vol 0.96x

2026-10-12S4

Wk 13 · Vol 0.40x

2026-10-09S4

Wk 13 · Vol 0.22x

2026-10-08S4

Wk 13 · Vol 0.07x

2026-10-07S4

Wk 12 · Vol 0.51x

Moving averages & range

50 DMA

$4.50

200 DMA

$5.34

52W High

$14.43

52W Low

$3.23

5D Low

$3.23

Resistance levels (recent highs)

20d High

$4.66

60d High

$5.28

120d High

$8.10

250d High

$14.43

Next resistance

+44.1%

to 20d High

ROE

-67.0%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 1.0

iTonic Holdings: quick answers

What stage is iTonic Holdings in?

As of Oct 22, 2026, iTonic Holdings (ITOC) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 15, 2026 and is in week 15. What the four stages mean

Is iTonic Holdings in an uptrend?

No. iTonic Holdings is in a Stage 4 downtrend. It trades 39.5% below its 200-day average, which is falling.

How far is iTonic Holdings from its 52-week high?

iTonic Holdings closed at $3.23 on Oct 22, 2026, 77.6% below its 52-week high of $14.43. Its 52-week low is $3.23.

How has iTonic Holdings performed over the past year?

As of Oct 22, 2026, iTonic Holdings is down 68.0% over the past year and down 53.5% so far in 2026.

Which sector and industry is iTonic Holdings in?

iTonic Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.